Nuvation Bio
Marvin L. has extensive work experience in IT and information management roles. Marvin most recently worked at Nuvation Bio as a Sr. Director of Information Management and Technology starting in March 2022. Before that, they were a Sr. Director of Information Services at Adamas Pharmaceuticals from August 2021 to February 2022. Marvin also served as the Director of IT Business Partnering World Wide Commercial Operations at Bristol Myers Squibb from November 2020 to August 2021. Prior to that, they were the Director of Commercial IT and Information Management at MyoKardia, which was later acquired by Bristol Myers Squibb, from November 2019 to November 2020. Marvin's other notable positions include Director of IT Applications (Commercial and G&A) at Nektar Therapeutics from April 2019 to November 2019 and Head of Information Management at Actelion (now Janssen Pulmonary Hypertension) from June 2010 to April 2019. Marvin started their career in R&D IT at Gilead Sciences from March 2004 to June 2010.
Marvin L. attended the University of California, Davis. The specific degree and field of study have not been provided.
This person is not in any offices
Nuvation Bio
2 followers
Nuvation Bio (NYSE: NUVB) is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.